Form 4: Senseonics Director Edward Fiorentino Receives Significant Equity Grants Under Compensation Policy

Senseonics Holdings, Inc. Director Edward Fiorentino was granted 111,386 Restricted Stock Units and 157,234 stock options as part of the company's non-employee director compensation policy.

Summary

• Edward Fiorentino, a Director at Senseonics Holdings, Inc. (SENS), acquired 111,386 shares of common stock through Restricted Stock Units (RSUs) and 157,234 stock options on May 23, 2025.
• The RSUs were granted at a price of $0, with each RSU representing a contingent right to receive one share of the Issuer's common stock.
• The stock options have an exercise price of $0.51 per share and are set to expire on May 22, 2035.
• Both the RSUs and stock options will vest in full on the earlier of the one-year anniversary of the grant date or the next annual stockholders meeting, contingent on Mr. Fiorentino's continuous service.
• Following these transactions, Mr. Fiorentino beneficially owns 1,315,427 shares of common stock and 157,234 stock options.
• These equity grants were made pursuant to Senseonics' established non-employee director compensation policy.

Sentiment

Score: 7

Explanation: The filing reports a routine equity grant to a director as part of a compensation policy, which is a neutral to slightly positive event as it aligns management interests with shareholders. It does not contain any negative operational or financial news.

Positives

• The grant of 111,386 Restricted Stock Units (RSUs) and 157,234 stock options to Director Edward Fiorentino aligns his financial interests directly with those of the shareholders, incentivizing long-term company performance.
• The compensation is part of a formal 'non-employee director compensation policy,' indicating a structured and transparent approach to corporate governance.

Negatives

• No specific negative financial or operational information is disclosed in this Form 4 filing, as it primarily reports routine insider equity transactions.

Risks

• The vesting of both the 111,386 RSUs and 157,234 stock options is contingent upon the Reporting Person's continuous service through the vesting date, meaning the benefits are tied to continued tenure.

Future Outlook

The vesting schedule for the RSUs and stock options, contingent on continuous service until the earlier of one year from the grant date or the next annual stockholders meeting, implies an expectation of continued tenure for Director Edward Fiorentino.

Management Comments

• "Represents a restricted stock unit ('RSU') grant pursuant to the Issuer's non-employee director compensation policy (the 'Policy')."
• "The RSUs vest in full on the earlier of the one year anniversary of the date of grant or the next annual stockholders meeting, subject to the Reporting Person's continuous service through such vesting date."
• "Represents a stock option grant pursuant to the Policy."
• "The options vest in full on the earlier of the one year anniversary of the date of grant or the next annual stockholders meeting, subject to the Reporting Person's continuous service through such vesting date."

Industry Context

The grant of equity compensation, including Restricted Stock Units (RSUs) and stock options, to non-employee directors is a common practice across publicly traded companies, particularly in the biotechnology and medical device sectors like Senseonics Holdings, Inc. This method is widely used to attract and retain qualified board members and to align their long-term interests with those of the company's shareholders.

Comparison to Industry Standards

• The compensation structure, involving RSUs and stock options with service-based vesting, is a standard approach for non-employee director compensation in the U.S. public market.
• Companies like Dexcom (DXCM) or Abbott Laboratories (ABT), also in the medical device or healthcare technology space, often utilize similar equity-based compensation plans for their independent directors to foster long-term commitment and incentivize value creation.
• The specific amounts granted would typically be benchmarked against peer companies of similar market capitalization and industry to ensure competitive and appropriate compensation.

Corporate Governance

Related Party Transactions

• The grant of equity compensation (111,386 RSUs and 157,234 stock options) to Edward Fiorentino, a director of Senseonics Holdings, Inc., constitutes a related party transaction. This is a standard and disclosed form of compensation for non-employee directors, governed by the company's established policy.

Stakeholder Impact

• Shareholders: The equity grants align the director's financial interests with those of the shareholders, potentially incentivizing long-term value creation and strategic decision-making.
• Management/Directors: Edward Fiorentino's compensation structure is enhanced, potentially increasing his commitment and motivation towards the company's long-term success.

Next Steps

• Vesting of the 111,386 RSUs and 157,234 stock options will occur on the earlier of May 23, 2026 (one-year anniversary) or the next annual stockholders meeting, subject to Edward Fiorentino's continuous service.

Key Dates

Recommendation

Keywords

Senseonics Holdings, SENS, Form 4, Insider Transaction, Director Compensation, Restricted Stock Units, RSU, Stock Options, Equity Grant, Corporate Governance